Impact Stories

Filter:

Remdesivir

Understanding how the conditionally approved COVID-19 drug works is key to improving treatments, says researcher.

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac)

UM researchers in the Rady Faculty of Health Sciences, in collaboration with the University of Minnesota and McGill University, have launched an online